Hyosung Chemical Corporation

KRX:298000.KS

41150 (KRW) • At close October 17, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) KRW.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q2
Revenue 754,482710,348686,532.897711,724.85723,850.932669,520.687682,095.387702,858.128766,390.299727,214.366612,025.608630,624.822619,163.878591,175.914475,712.959487,343.69429,337.665424,795.666417,106.413455,854.552488,006.761451,502.67489,162.324491,780.332135,829.488
Cost of Revenue 777,576.724717,438.252695,473.304688,461.781798,141.678687,346.215751,300.87815,095.18807,020.414735,298.009601,477.109571,930.813523,561.714506,746.021432,794.668440,883.573400,912.464389,546.258368,202.994378,637.6416,697.672405,346.575451,878.54433,741.581116,549.13
Gross Profit -23,094.724-7,090.252-8,940.40723,263.069-74,290.746-17,825.527-69,205.483-112,237.052-40,630.115-8,083.64310,548.49858,694.00995,602.16484,429.89342,918.29146,460.11728,425.20135,249.40848,903.4277,216.95271,309.08946,156.09537,283.78458,038.75119,280.358
Gross Profit Ratio -0.031-0.01-0.0130.033-0.103-0.027-0.101-0.16-0.053-0.0110.0170.0930.1540.1430.090.0950.0660.0830.1170.1690.1460.1020.0760.1180.142
Reseach & Development Expenses 5,193.1125,181.5354,448.3394,769.0865,279.6755,748.3274,928.0695,153.2795,485.4695,315.8695,659.8875,439.5615,288.8255,394.5234,696.6024,826.7255,282.5595,397.2764,914.0625,115.9715,495.1155,467.9055,811.4955,676.9292,077.846
General & Administrative Expenses 22,431.90522,557.915026,097.94428,979.33721,693.706-52,950.51522,373.52621,965.96519,774.285-48,216.76520,366.51718,975.07717,931.429-44,138.83816,771.77519,572.12617,446.244-37,710.7917,041.65916,225.09215,740.233-13,984.09616,056.3064,913.791
Selling & Marketing Expenses -0000000000000000000000000
SG&A 22,431.90522,557.91524,074.93326,097.94428,979.33721,693.706-20,259.51522,373.52621,965.96519,774.285-18,702.76520,366.51718,975.07717,931.429-18,817.83816,771.77519,572.12617,446.244-13,407.7917,041.65916,225.09215,740.233-1,351.09616,056.3064,913.791
Other Expenses -805,201-745,177-723,996.564-52,195.888-57,958.67349.36441,834-273.7121,602.359-1,624.1482,866.795-341.5931,115.6441,436.035-924.966-396.25607.66962.906-1,620.186-529.226535.103-390.992-511.665-387.841-481.161
Operating Expenses 805,201745,17728,523.272-26,097.944-28,979.33627,442.03326,502.55327,526.80527,451.43525,090.15327,306.12225,806.07824,263.90323,325.95222,828.76421,598.524,854.68522,843.52124,612.27222,157.6321,720.20721,208.13820,883.24221,733.2356,991.637
Operating Income -50,719-34,829-37,463.679-2,834.875-103,270.082-50,484.465-95,708.036-139,763.858-68,081.55-37,232.541-16,757.62432,887.93271,338.26261,103.94120,089.52824,861.6173,570.51612,405.88824,291.14855,059.32249,588.88224,947.95716,400.54336,305.51712,288.72
Operating Income Ratio -0.067-0.049-0.055-0.004-0.143-0.075-0.14-0.199-0.089-0.051-0.0270.0520.1150.1030.0420.0510.0080.0290.0580.1210.1020.0550.0340.0740.09
Total Other Income Expenses Net -46,809-45,756-47,319.031-48,946.729-44,255.908-36,651-44,046.445-31,295.319-18,833.143-13,290-10,804-34,550.691-7,241.748-7,598.019-22,143.125-11,698.013-12,661.571-11,003.486-10,596.971-8,188.25-12,418.801-12,669.525-21,163.175-7,296.782-9,116.859
Income Before Tax -97,528-80,585-84,782.71-51,781.604-147,525.99-87,135.465-139,754.481-171,059.176-86,914.693-50,522.541-27,375.14924,143.31864,096.51353,505.922-2,053.59713,163.604-9,091.0551,402.40113,694.17646,871.07137,170.08112,278.432-4,762.63329,008.7343,171.862
Income Before Tax Ratio -0.129-0.113-0.123-0.073-0.204-0.13-0.205-0.243-0.113-0.069-0.0450.0380.1040.091-0.0040.027-0.0210.0030.0330.1030.0760.027-0.010.0590.023
Income Tax Expense -7,462-6,682-11,340.369-3,747.382-5,074.428-4,818.164-19,961.517-19,261.713784.968-945.8494,921.38310,143.78317,271.50711,619.6214,003.2656,818.413,865.51350.6584,634.22510,233.2538,530.397-1,207.563759.3635,615.267648.473
Net Income -90,066-73,903-74,109.595-48,034.222-142,451.562-82,317.3-119,792.964-151,797.463-87,699.661-49,576.692-32,296.53213,999.53546,825.00641,886.301-6,056.8626,345.194-12,956.5641,051.7449,059.95136,637.81828,639.68413,485.995-5,521.99523,393.4672,523.389
Net Income Ratio -0.119-0.104-0.108-0.067-0.197-0.123-0.176-0.216-0.114-0.068-0.0530.0220.0760.071-0.0130.013-0.030.0020.0220.080.0590.03-0.0110.0480.019
EPS -27,542.21-22,599.56-20,239.34-15,115.58-44,653.9-25,903.91-37,696.88-47,768.17-27,598-15,601-10,163.794,406.2314,73513,181-1,9061,997-4,0773312,851.0211,5299,0124,244-1,737.47,352791
EPS Diluted -27,542.21-22,599.56-20,239.34-15,115.58-44,653.9-25,903.91-37,696.88-47,768.17-27,597.65-15,600.97-10,163.194,406.2314,73513,181-1,9061,997-4,0773312,851.0211,5299,0124,244-1,735.437,352791
EBITDA -50,719-34,8296,248.32123,263.069-74,290.74618,373.535-5,883.481-89,122.176-9,143.69333,053.45940,244.85170,654.318118,674.17103,779.26564,884.40378,700.60457,099.65735,814.34671,995.67782,048.489,531.79357,397.05641,963.56776,636.52212,288.721
EBITDA Ratio -0.067-0.0490.0090.033-0.1030.027-0.009-0.127-0.0120.0450.0660.1120.1920.1760.1360.1610.1330.0840.1730.180.1830.1270.0860.1560.09